14-day Premium Trial Subscription Try For FreeTry Free
Currently predicting for Thu, 9 May 2024

Trading levels for RLMD

Fibonacci Support & Resistance Levels

Level Price
Resistance R3 4.04 5.56 %
R2 3.97 3.57 %
R1 3.92 2.34 %
Current price: 3.83
Support S1 3.77 -1.64 %
S2 3.72 -2.86 %
S3 3.64 -4.85 %

Accumulated Volume Support & Resistance Levels

Level Price
Resistance R3 4.69 22.45 %
R2 4.66 21.67 %
R1 4.44 15.80 %
Current price 3.83
Support S1 3.68 -3.92%
S2 3.64 -4.96%
S3 3.53 -7.83%

RLMD Predictions History

1 year ago
elitepowerwashllc.341511 predicted that RLMD for 2022-10-03 is going

Rank:

4 years ago
JS predicted that RLMD for 2020-01-27 is going

4 years ago
JosephProxmire128101 predicted that RLMD for 2020-01-27 is going

Rank:

4 years ago
coryrose128277 predicted that RLMD for 2019-12-11 is going

Rank:

4 years ago
PumpTheseNumbers predicted that RLMD for 2019-12-03 is going $33.82 (-1.86%)

4 years ago
Fazil Ally predicted that RLMD for 2019-12-03 is going

Rank:
Click to get the best stock tips daily for free!

About Relmada Therapeutics, Inc.

Relmada Therapeutics. Relmada Therapeutics, Inc., a clinical-stage biotechnology company, focuses on developing various products for the treatment of central nervous system (CNS) diseases and other disorders. Its lead product candidate is Esmethadone (d-methadone, dextromethadone, and REL-1017), a new chemical entity and N-methyl-D-aspartate receptor antagonist that is in Phase 3 clinical trials for the adjunctive or monotherapy treatment of major depressive disorder ... RLMD Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT